Most Active Volume Surge: Inspire Pharma (ISPH)

Posted in General 
June 6th, 2008

The leader in pre-market trading this Friday is Inspire Pharmaceuticals Inc. (NASDAQ: ISPH). The small biotech is scoring huge gains in pre-market trading after its Phase III trial of Denufosol for Cystic Fibrosis met primary endpoints.

With 45 minutes to go before the open, this has already traded over 1.1 million shares, way above the 224,000 average daily volume. Yep, over 4-times volume and we still have 45 minutes before the open.

Shares closed at $3.85 yesterday, and shares are currently at $5.95 in pre-market trading. Just a few minutes ago shares had trades up at $6.40, so be sure not to underestimate the whipsaws of this small-cap biotech stock. Before the pop, this was a $217 million market cap. Its 52-week trading range is $2.89 to $7.27.

A full summary and brief analysis of the actual data can be found at BioHealthInvestor.com.

Jon Ogg
June 6, 2008

Leave a Reply

You must be logged in to post a comment.

-->